2026-01-18 - Analysis Report
**English Report**

### **Company Overview**
Intuitive Surgical Inc is a robotics and medical device company. 

### **Return Rate Comparison**

* Review Stock (ISRG): 69.99% 
* Comparison Stock (S&P 500, VOO): 93.36%
* Divergence (max:-47.80, min: 73.30, current: -21.50, relative divergence: 21.70%)

The review stock's cumulative return is lower than the comparison stock's cumulative return.

### **Alpha, Beta Analysis**

| Year       | CAGR | MDD  | Alpha | Beta | Cap(B) |
|------------|------|------|-------|------|-------|
| 2016-2018  | 49.0% | 29.0% | 45.0% | 1.2 | 57.2B |
| 2017-2019  | 40.0% | 29.0% | 23.0% | 1.4 | 70.6B |
| 2018-2020  | -8.0% | 29.0% | -29.0% | 1.2 | 97.8B |
| 2019-2021  | 26.0% | 21.1% | -17.0% | 1.2 | 128.8B |
| 2020-2022  | -18.0% | 48.9% | -16.0% | 1.2 | 95.1B |
| 2021-2023  | -12.0% | 48.9% | -13.0% | 1.4 | 120.9B |
| 2022-2024  | 35.0% | 38.0% | 16.0% | 1.3 | 187.1B |
| 2023-2025  | 60.0% | 28.0% | -2.0% | 1.2 | 203.0B |

### **Price Fluctuations**

* Close: $535.00 
* Last-Market: -$6.34 (-1.17%)
* 5-day SMA: $551.53
* 20-day SMA: $570.17
* 60-day SMA: $560.99

The 5-day SMA and close price indicate a downward trend.

### **RSI, PPO Indicators**

* Market Risk Indicator (MRI): 0.80
* RSI: 29.97
* PPO: -0.99
* Expected Return (%): 7.20%

The market risk indicator and RSI indicate a relatively high risk investment.

### **Recent News & Significant Events**

Recent significant events include the following: 
- Why This Robotics Giant Crumbled Despite Its Quarterly Beat - Investor's Business Daily
- Why Intuitive Surgical Stock Dropped Today - The Motley Fool
- Intuitive Surgical: Buying The Dip On This Wide-Moat Compounder 
- da Vinci 5 Expands Globally: Can ISRG Beat Overseas Cost Hurdles?
- Intuitive Surgical: DV5 Adoption, Innovation Pipeline, and Robust Growth Outlook Support Premium-Valued Buy Rating
- Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030

These news articles indicate recent downward stock movement.

### **Analyst Opinions**

Analyst Consensus:
- Key: Buy
- Mean (1=StrongBuy~5=Sell): 2.06 (~Buy)
- Opinions: 29
- Target Price (avg/high/low): $608.26 / $740.00 / $378.00

Buy recommendations from analysts indicate potential positive price movement.

### **Recent Earnings Analysis**

| Date | EPS | Revenue |
|---|---:|---:|
| 2025-10-22 | 1.98 | $2.51 B$ |
| 2025-07-23 | 1.84 | $2.44 B$ |
| 2025-04-23 | 1.95 | $2.25 B$ |
| 2024-10-18 | 1.59 | $2.04 B$ |
| 2025-10-22 | 1.59 | $2.04 B$ |

### **Revenue and Profitability Analysis**

| Quarter | Revenue | Profit Margin |
|---------|----------|---------------|
| 2025-09-30 | $2.51B | 66.36% |
| 2025-06-30 | $2.44B | 66.31% |
| 2025-03-31 | $2.25B | 64.69% |
| 2024-12-31 | $2.41B | 68.04% |
| 2024-09-30 | $2.04B | 67.41% |

The company has experienced a steady increase in revenue with relatively stable profit margins.

### **Capital and Profitability Analysis**

| Quarter | Equity | ROE |
|---------|---------|-----|
| 2025-09-30 | $16.93B | 4.16% |
| 2025-06-30 | $17.85B | 3.69% |
| 2025-03-31 | $17.11B | 4.08% |
| 2024-12-31 | $16.43B | 4.17% |
| 2024-09-30 | $15.58B | 3.63% |

The company's equity has increased over the past year with relatively stable return on equity.

**Comprehensive Analysis**
Recent stock movement indicates downward trends, but buy recommendations from analysts suggest potential positive price movement. The company's revenue has increased steadily with relatively stable profit margins and return on equity.

**Disclaimer:** This report is for informational purposes only and does not constitute financial advice. Investment involves risk.